-transparent.png){kind=logo}
Dipropylacetic acid (DPA), gamma-aminobutyric acid (GABA), physostigmine, CB 154 and butyrophenones were administered to 26 patients affected by Huntington's chorea. The evaluation of the pharmacologic activity of the different drugs was determined by means of some clinical parameters and motor performance tests. Butyrophenones succeeded to ameliorate the hyperkinesias and the motor dexterity, CB 154 provoked a worsening of the motor signs of the disorder, while DPA, GABA and physostigmine did not modify the clinical pattern. The relationship between these results and the Hungtington's chorea physiopathology is discussed and a hypersensitivity of DA receptors is suggested.
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
June 1985,
Journal de genetique humaine,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
June 1962,
Diseases of the nervous system,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
January 1970,
Przeglad lekarski,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
October 1980,
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
January 1957,
La Revue du praticien,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
September 1967,
Archives of neurology,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
March 1954,
Laval medical,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
January 1908,
Proceedings of the Royal Society of Medicine,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
April 1967,
Journal of the Iowa Medical Society,
T Caraceni, and
P Giovannini, and
F Girotti, and
G Avanzini
November 1964,
Nursing times,
